The Peruvian Penicillins and Streptomycins dosage market stood at $2.49 per capita in 2023. The growth has been moderate from 2013, with a peak in 2016 and fluctuations since. Noteworthy is the positive yet minimal CAGR over the past five years, indicating a slow growth trend. Comparing 2023 to 2022 shows a slight improvement from $2.45, suggesting modest recovery or stabilization. Year-on-year comparisons for 2022-2023 reflect a 1.63% increase.
Future trends to watch include potential impacts of policy changes, healthcare access, and antibiotic resistance. Pharmaceutical innovation and epidemiological shifts may also influence market dynamics.
| # | 31 Countries | US Dollars Per Capita | Last Year | |||
|---|---|---|---|---|---|---|
| 1 | 1 Italy | 11.76 | 2023 | View data | ||
| 2 | 2 New Zealand | 11.59 | 2023 | View data | ||
| 3 | 3 France | 11.21 | 2023 | View data | ||
| 4 | 4 Belgium | 11.17 | 2023 | View data | ||
| 5 | 5 United Kingdom | 10.77 | 2023 | View data | ||
| 17 | 17 Vietnam | 2.56 | 2023 | View data | ||
| 18 | 18 Bolivia | 2.5 | 2023 | View data | ||
| 19 | 19 Peru | 2.49 | 2023 | |||
| 20 | 20 Nicaragua | 2.37 | 2023 | View data | ||
| 21 | 21 Guatemala | 2.36 | 2023 | View data | ||
